Live | Norge | Sverige | Danmark | Europa | USA | Valuta | Råvarer | Gråmarked | Fond | NDXForsinkede kurser. Sist oppdatert: mandag 16. juli
Oversikt
Kursliste
Indekser
Nyheter
Største handler
Tegningsretter
Historikk
Vinnere/tapere
Høy/lav

16/04-2018 15:50:49: (PHO) Photocure ASA: Annual accounts 2017

Photocure ASA: Annual accounts 2017



Oslo, 16 April 2018: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2017.

The annual accounts and annual report for the financial year 2017 are enclosed with this notification and made available on the company's website, www.photocure.com.  

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000, Email: ed@photocure.no

About Photocure ASA

Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at www.photocure.com, www.hexvix.com, www.cysview.com.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Photocure ASA via Globenewswire


Nyheten er levert av GlobeNewswire.

Utforming |  Hjelp |  Utskrift  | Bytt til sanntid  Åpne markeder: Nasdaq, Nyse, Amex
mandag 16/07-2018 18:34:31